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Background:  Coronary stress flow (CSF) and coronary flow reserve (CFR) has been recognized as noninvasive indicators of functional 
significance of coronary stenosis. We studied the diagnostic performance of CSF and CFR by 13N-Ammonia Positron Emission 
Tomography (PET) for detection of obstructive Coronary Artery Disease (CAD) diagnosed by Coronary Computed Tomography 
Angiography (CCTA).
methods:  We retrospectively included 278 patients referred to our unit due to suspected CAD (61% male, 62.5 ± 11.1 years). PET with 
13N-Ammonia was performed during rest and pharmacological stress with adenosine (Biograph True Point PET/CT 64-Multislice Scanner; 
Siemens Medical, Erlangen, Germany), CSF and CFR were analyzed by automated QPET software; all patients underwent a CCTA. 
Study Receiver Operating Characteristic curve was used to define the best threshold for CSF and CFR in the detection of ≥70% diameter 
coronary stenosis in CCTA. We performed a multivariate analysis to demonstrate predictors of obstructive CAD.
results:  In a per vessel analysis, CFR ≤ 2.59 mL/min/g for detecting obstructive CAD had sensitivity of 80%, specificity of 55%, and 
negative predictive value of 98.6%; CSF ≤ 1.91 mL/min/g had a similar accuracy for detecting obstructive CAD with sensitivity of 80%, 
specificity of 62%, and negative predictive value of 98.8% (p=NS for all).  In a multivariable logistic regression analysis, the strongest 
independent predictor of obstructive CAD was CSF (OR: 4.93, 95% IC: 1.93-12.57, p=0.001), followed by previous myocardial infarction 
(OR: 4.03, 95% IC: 1.53-10.62, p=0.005), diabetes mellitus (OR: 2.5, 95% IC: 1.11-5.59, p=0.02), >65 years (OR 2.31, 95% IC: 1.01-5.25, 
p=0.04), and previous angina (OR 1.47, 95% IC: 0.54-4.00, p=0.44); CFR was not an independent predictor of obstructive CAD (OR: 1.6, 
p=NS).
conclusion:  The quantification on CSF and CFR with pharmacological stress 13N-Ammonia PET scan had a similar diagnostic 
performance, however, CSF ≤ 1.91 mL/min/g was the strongest independent predictor of obstructive CAD.  Our study provides a cut-off 
value for quantitative non-invasive tool for detecting obstructive CAD, in a real world scenario.
